A nurse is teaching a client who has a new prescription for gemfibrozil. Which of the following findings should the nurse instruct the client to report as an adverse effect of the medication?
Tinnitus
Decreased LDL level
Epigastric pain
Weight gain
The Correct Answer is C
Gemfibrozil is a fibrate used to treat hypertriglyceridemia by activating peroxisome proliferator-activated receptor-alpha. It reduces very-low-density lipoprotein levels but can cause significant gastrointestinal distress and hepatobiliary complications. A critical risk includes the development of cholelithiasis or myopathy, especially when the medication is administered concurrently with certain other lipid-lowering agents.
Rationale:
A. Tinnitus, or ringing in the ears, is not a recognized or common adverse effect associated with gemfibrozil therapy. This symptom is more frequently linked to ototoxic medications like aminoglycosides or high-dose aspirin. Patients taking fibrates are not generally monitored for auditory changes as part of the standard safety profile for this drug class.
B. A decreased LDL level is a therapeutic goal and expected outcome of lipid-lowering therapy, not an adverse effect. Gemfibrozil is primarily indicated to lower triglycerides and increase HDL, though it may also modestly lower LDL. Reporting a desired clinical improvement would not be necessary in the context of identifying harmful medication reactions.
C. Epigastric pain must be reported because gemfibrozil can cause biliary stasis, increasing the risk of gallstones and cholecystitis. It can also cause generalized dyspepsia and, in more severe cases, contribute to pancreatitis. If a client experiences upper abdominal pain, the nurse must assess for potentially serious hepatobiliary or pancreatic complications immediately.
D. Weight gain is not a typical side effect of gemfibrozil; in fact, the medication does not significantly impact adipose tissue accumulation. Most gastrointestinal side effects of fibrates involve nausea or abdominal discomfort, which would more likely lead to a decrease in appetite. Unexplained weight gain would require investigation into other metabolic or cardiac etiologies.
Nursing Test Bank
Naxlex Comprehensive Predictor Exams
Related Questions
Correct Answer is D,A,C,B
Explanation
Inject 5 units of air into the NPH insulin vial.
Inject 15 units of air into the regular insulin vial.
Withdraw 15 units of medication from the regular insulin vial.
Withdraw 5 units of medication from the NPH insulin vial.
Brief Introduction:
Insulin mixturepreparation requires a specific sequence to prevent cross-contamination of vials and ensure dosage accuracy. Regular insulinis a short-acting, clear solution, while NPH insulinis an intermediate-acting, cloudy suspension. Maintaining the "clear before cloudy" withdrawal rule is a critical safety standard in clinical pharmacology to avoid contaminating the fast-acting clear vial with the protein-binding agents found in the NPH suspension.
Rationale:
A. Injecting 15 units of air into the regular insulinvial is the second step in the sequence. After the NPH vial has been pressurized with air, the needle is withdrawn and inserted into the clear vial. This ensures that the clear insulin vial is ready for immediate withdrawal without needing to re-enter the cloudy vial later, which maintains the chemical purityof the short-acting insulin.
B. Withdrawing 5 units of medication from the NPH insulinvial is the final step of the procedure. Because NPH contains protamine, any accidental backflow into the regular vial would alter the clear insulin's pharmacokinetic properties. By withdrawing the cloudy insulin last, the nurse ensures the integrity of the fast-acting dose, which is essential for managing postprandial glucose spikes.
C. Withdrawing 15 units of medication from the regular insulinvial occurs after air has been injected into both vials. The clear insulin is always drawn up first into the syringe to ensure that no cloudy suspensionenters the clear vial. This order is a standard nursing competency designed to prevent the modification of the onset and peak action of the clear insulin dose.
D. Injecting 5 units of air into the NPH insulinvial is the initial step in preparing a mixed dose. Vials are sealed vacuum environments; therefore, air equal to the dose must be injected to allow for the easy displacement of fluid. Starting with the cloudy vialfor air injection (without the needle touching the solution) allows the nurse to then move to the clear vial for the withdrawal phase.
Correct Answer is A
Explanation
The pharmacological management of acute maniainvolves mood stabilizers and antipsychotics to achieve rapid symptomatic control. Safety standards prohibit the use of trailing zerosin medication orders to prevent ten-fold dosing errors. A decimal point followed by a zero can be easily misread in a clinical environment, leading to iatrogenic harmand severe medication toxicity.
Rationale:
A.Risperidone 3.0 mg contains a trailing zero, which is a dangerous notation that must be clarified and corrected to 3 mg. If the decimal point is not clearly visible, a clinician might mistakenly administer 30 mg, which could lead to severe extrapyramidal symptoms or neuroleptic malignant syndrome. Following the "Do Not Use" list from The Joint Commission is essential for patient safety.
B.Clonazepam 0.5 mg is a correctly formatted prescription for a benzodiazepine often used as an adjunct in mania to promote sedation and reduce agitation. The leading zero before the decimal point is required to prevent the dose from being read as 5 mg. Since this order follows safe labeling practices and falls within therapeutic ranges, it does not require clarification.
C.Lithium 300 mg is a standard starting dose for a primary mood stabilizer used in the treatment of bipolar disorder. The order is written clearly without dangerous abbreviations or incorrect decimal placements. Because the dose is typical for achieving a therapeutic serum concentration between 0.8 and 1.2 mEq/L, the nurse can proceed with administration and monitoring.
D.Divalproex sodium 0.5 g is an anticonvulsant mood stabilizer written using a leading zero, which is the correct safety format for decimal values. While often prescribed in milligrams (500 mg), the use of grams is clear and follows standard metric notation. There is no ambiguity in this order that would increase the risk of a significant medication error for the patient.
Whether you are a student looking to ace your exams or a practicing nurse seeking to enhance your expertise , our nursing education contents will empower you with the confidence and competence to make a difference in the lives of patients and become a respected leader in the healthcare field.
Visit Naxlex, invest in your future and unlock endless possibilities with our unparalleled nursing education contents today
Report Wrong Answer on the Current Question
Do you disagree with the answer? If yes, what is your expected answer? Explain.
Kindly be descriptive with the issue you are facing.
